Search

Edwards Lifesciences Corp

Затворен

СекторЗдравеопазване

92.26 1.42

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

90.19

Максимум

91.64

Ключови измерители

By Trading Economics

Приходи

-139M

241M

Продажби

92M

1.7B

P/E

Средно за сектора

54.054

57.371

EPS

0.78

Марж на печалбата

13.866

Служители

16,000

EBITDA

20M

520M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+13.29% upside

Дивиденти

By Acuity

Следващи печалби

29.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

3.3B

52B

Предишно отваряне

90.84

Предишно затваряне

92.26

Настроения в новините

By Acuity

33%

67%

112 / 340 Класиране в Healthcare

Edwards Lifesciences Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.08.2026 г., 23:06 ч. UTC

Edwards Lifesciences shares are lower in after-market hours amid rising U.S. bond yields, contributing to market concerns despite recent softer economic data.

13.08.2026 г., 20:06 ч. UTC

Edwards Lifesciences shares are lower today, tracking a broader market decline. The stock remains above its 20-day moving average and near its one-month range.

12.08.2026 г., 22:16 ч. UTC

Edwards Lifesciences shares declined in after-market trading, despite earlier fluctuations. The stock remains above its 20-day moving average and near its one-month range.

11.08.2026 г., 19:21 ч. UTC

Edwards Lifesciences Corp is trading higher, maintaining upward momentum after four consecutive daily gains and peaking in the late morning session.

10.08.2026 г., 19:51 ч. UTC

Edwards Lifesciences shares are higher today, reflecting unusual strength above the 20-day moving average amid uncertainty over the Federal Reserve's interest rate policy.

7.08.2026 г., 19:16 ч. UTC

Edwards Lifesciences Corp. shares are higher today, fluctuating within a routine range since Thursday's close, currently trading above its 20-day moving average.

5.08.2026 г., 19:56 ч. UTC

Edwards Lifesciences shares are lower today, continuing a decline since Tuesday. The stock remains above its 20-day moving average.

4.08.2026 г., 19:36 ч. UTC

Edwards Lifesciences shares are higher amid positive market momentum, despite a notable decline in U.S. core factory orders reflecting weakening demand across sectors.

3.08.2026 г., 22:02 ч. UTC

Edwards Lifesciences Corp shares are lower in after-market hours, following a notable decline that reached a session low shortly after the market opened.

31.07.2026 г., 19:46 ч. UTC

Edwards Lifesciences shares are lower, reflecting broader market trends amid inflation and interest rate concerns. The stock is trading below its 20-day moving average.

30.07.2026 г., 22:06 ч. UTC

Edwards Lifesciences shares are trading lower in after-market hours, reflecting ongoing weakness and uncertainty following the Federal Reserve's interest rate decision.

29.07.2026 г., 23:46 ч. UTC

Edwards Lifesciences Corp shares are higher in after-market trading, following four consecutive sessions of gains. No specific news was identified to explain the movement.

28.07.2026 г., 18:46 ч. UTC

News

UBS analyst Danielle Antalffy initiated coverage on Edwards Lifesciences with a Buy rating and $110 price target, boosting shares modestly higher today.

27.07.2026 г., 19:41 ч. UTC

Social Media
News

Edwards Lifesciences shares rise as TAVR revenue hits $35 million, driven by a 10.5% increase in U.S. sales, surpassing expectations.

24.07.2026 г., 18:41 ч. UTC

News

Edwards Lifesciences Corp is trading lower today despite positive analyst ratings. The stock pulled back from an earlier session high and has declined since Thursday's close.

23.07.2026 г., 23:41 ч. UTC

News
Event

Edwards Lifesciences reported Q2 sales of $1.74 billion, exceeding expectations. Shares are gaining in after-market hours following the results and raised guidance.

22.07.2026 г., 18:46 ч. UTC

Edwards Lifesciences shares are trading higher during Wednesday's session, showing slight gains despite recent declines in the broader market.

21.07.2026 г., 21:02 ч. UTC

Edwards Lifesciences Corp shares are lower in after-market hours, continuing a trend of three consecutive sessions below the 20-day moving average.

20.07.2026 г., 19:56 ч. UTC

News

Edwards Lifesciences shares are lower as regulatory challenges arise from a $12 million FTC penalty and new restrictions on valve replacement agreements.

Сравнение с други в отрасъла

Ценова промяна

Edwards Lifesciences Corp Прогноза

Ценова цел

By TipRanks

13.29% нагоре

12-месечна прогноза

Среден 102.88 USD  13.29%

Висок 110 USD

Нисък 85 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Edwards Lifesciences Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

19 ratings

16

Купи

3

Задържане

0

Продай

Настроение

By Acuity

112 / 340 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
help-icon Live chat